The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 17, 2022
Filed:
Oct. 17, 2019
Applicant:
Clarus Therapeutics, Inc., Northbrook, IL (US);
Inventors:
Robert E. Dudley, Murfreesboro, TN (US);
Panayiotis P. Constantinides, Gurnee, IL (US);
Assignee:
Clarus Therapeutics, Inc., Northbrook, IL (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/568 (2006.01); A61K 47/44 (2017.01); A61K 47/10 (2017.01); A61K 9/48 (2006.01); A61K 31/22 (2006.01); A61K 31/573 (2006.01); A61K 47/12 (2006.01); A61K 47/14 (2017.01); A61K 47/26 (2006.01); C07J 1/00 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/107 (2006.01);
U.S. Cl.
CPC ...
A61K 31/568 (2013.01); A61K 9/0053 (2013.01); A61K 9/06 (2013.01); A61K 9/4858 (2013.01); A61K 31/22 (2013.01); A61K 31/573 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/26 (2013.01); A61K 47/44 (2013.01); C07J 1/00 (2013.01); A61K 9/1075 (2013.01);
Abstract
A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e.g., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided.